Notice Pursuant to the National Cooperative Research and Production Act of 1993; Cooperative Research Group on Separation Technology Research Program, 53215-53216 [2014-21286]
Download as PDF
<![CDATA[
rmajette on DSK2TPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices
collection instrument with instructions
or additional information, please
contact Jennifer Bickford, Acting
Assistant Deputy Chief, Asset Forfeiture
and Money Laundering Section, 1400
New York Avenue NW., Washington,
DC 20005 (phone: 202–514–1263).
Written comments and/or suggestions
can also be directed to the Office of
Management and Budget, Officer of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington DC 20503 or sent to
OIRA_submission@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of this Information
Collection 1123–0011:
1 Type of Information Collection:
Extension with changes, of the
Department of Justice Equitable Sharing
Agreement and Certification, a
previously approved collection for
which approval will expire on
September 30, 2014.
2 The Title of the Form/Collection:
Department of Justice Equitable Sharing
Agreement and Certification.
3 The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
There is not an agency form number.
The applicable component within the
Department of Justice is the Asset
Forfeiture and Money Laundering
Section, in the Criminal Division.
4 Affected public who will be asked
or required to respond, as well as a brief
abstract:
The Attorney General is required by
statute to ‘‘assure that any property
VerDate Mar<15>2010
15:14 Sep 05, 2014
Jkt 232001
transferred to a State or local law
enforcement agency . . . will serve to
encourage further cooperation between
the recipient State or local agency and
Federal law enforcement agencies.’’ 21
U.S.C. 881(e)(3). The Asset Forfeiture
and Money Laundering Section
(AFMLS) ensures such cooperation by
requiring that all such ‘‘equitably
shared’’ funds be used only for law
enforcement purposes and not be
distributed to other governmental
agencies by the recipient law
enforcement agencies. By requiring that
law enforcement agencies that
participate in the Equitable Sharing
Program (Program) file an Equitable
Sharing Agreement and Certification
(ESAC), AFMLS can readily ensure
compliance with its statutory
obligations.
The ESAC requires information
regarding the receipt and expenditure of
Program funds from the participating
agency. Accordingly, it seeks
information that is exclusively in the
hands of the participating agency.
5 An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 7,600 state and
local law enforcement agencies
electronically file the ESAC annually
with AFMLS. It is estimated that it takes
30 minutes per year to enter the
information. All of the approximately
7,600 agencies must fully complete the
form each year to maintain compliance
and continue participation in the
Department of Justice Equitable Sharing
Program.
6 An estimate of the total public
burden (in hours) associated with the
collection: The estimated public burden
associated with this collection is 3,800
hours. It is estimated that respondents
will take 30 minutes to complete the
form. (7,600 participants × 30 minutes =
3,800 hours).
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Room
3E.405B, Washington, DC 20530.
Dated: September 3, 2014.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2014–21281 Filed 9–5–14; 8:45 am]
BILLING CODE 4410–14–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
53215
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993; Cooperative Research
Group on Separation Technology
Research Program
Notice is hereby given that, on August
8, 2014, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Southwest Research
Institute—Cooperative Research Group
on Separation Technology Research
Program (‘‘STAR’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: Aker Process Systems,
Fornebu, Norway; Amistco Separation
Products, Inc, dba AMACS Process
Tower Internals, Houston, TX; Chevron
Energy Technology Co., a Division of
Chevron USA, Inc., Houston, TX;
ExxonMobil Upstream Research Co.,
Houston, TX; FMC Separation Systems
B.V., Arnhem, The Netherlands; Frames
Separation Technologies B.V., Utrecht,
The Netherlands; KGGP, LLC, Wichita,
KS; Linde Engineering North America
Inc., Blue Bell, PA; PetroSkills, LLC,
Katy, TX; Rhodius GmbH, Bayern,
Germany; Shell International
Exploration and Production Inc.,
Houston, TX; Total E&P Recherche Et
Developpement, Paris, France; Wartsila
Oil & Gas Systems AS, Asker, Norway;
Sulzer Chemtech Ltd., Winterthur,
Switzerland; and OneSubsea LLC,
Houston, TX. The general area of
STAR’s planned activity is to increase
fundamental knowledge of separation
technology for use in the oil and gas
industry. This will be accomplished by
conducting research related to
separation technology as well as
through conducting systematic testing
on and enabling qualification of
separation equipment. STAR will also
develop standardized procedures for
testing equipment and conduct
fundamental research on separation
technology for use by the separation
E:\FR\FM\08SEN1.SGM
08SEN1
53216
Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices
equipment manufacturers, separation
system designers, and end users.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2014–21286 Filed 9–5–14; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–393]
Established Aggregate Production
Quotas for Schedule I and II Controlled
Substances and Assessment of
Annual Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2015
Drug Enforcement
Administration (DEA), Department of
Justice (DOJ).
ACTION: Notice.
AGENCY:
This notice establishes the
initial 2015 aggregate production quotas
for controlled substances in schedules I
and II of the Controlled Substances Act
(CSA) and the assessment of annual
needs for the list I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine.
DATES: Effective date: Effective
September 8, 2014.
FOR FURTHER INFORMATION CONTACT:
Imelda Paredes, Executive Assistant,
Office of Diversion Control, Drug
Enforcement Administration, 8701
Morrissette Drive, Springfield, VA
22152, Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION:
rmajette on DSK2TPTVN1PROD with NOTICES
SUMMARY:
Legal Authority
The Drug Enforcement
Administration (DEA) implements and
enforces titles II and III of the
Comprehensive Drug Abuse Prevention
and Control Act of 1970, as amended.
Titles II and III are referred to as the
‘‘Controlled Substances Act’’ and the
‘‘Controlled Substances Import and
Export Act,’’ respectively, and are
collectively referred to as the
‘‘Controlled Substances Act’’ or the
‘‘CSA’’ for the purpose of this action. 21
U.S.C. 801–971. The DEA publishes the
implementing regulations for these
statutes in title 21 of the Code of Federal
Regulations (CFR), parts 1300 to 1321.
The CSA and its implementing
regulations are designed to prevent,
detect, and eliminate the diversion of
controlled substances and listed
chemicals into the illicit market while
providing for the legitimate medical,
scientific, research, and industrial needs
VerDate Mar<15>2010
15:14 Sep 05, 2014
Jkt 232001
of the United States. Controlled
substances have the potential for abuse
and dependence and are controlled to
protect the public health and safety.
Section 306 of the Controlled
Substances Act (CSA) (21 U.S.C. 826)
requires the Attorney General to
establish aggregate production quotas
for each basic class of controlled
substance listed in schedules I and II
and for ephedrine, pseudoephedrine,
and phenylpropanolamine. This
responsibility has been delegated to the
Administrator of the DEA through 28
CFR 0.100(b). The Administrator, in
turn, has redelegated this function to the
Deputy Administrator, pursuant to 28
CFR pt. 0 subpt. R, App.
Background
The 2015 aggregate production quotas
and assessment of annual needs
represent those quantities of schedule I
and II controlled substances and the list
I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine to be
manufactured in the United States in
2015 to provide for the estimated
medical, scientific, research, and
industrial needs of the United States,
lawful export requirements, and the
establishment and maintenance of
reserve stocks. These quotas include
imports of ephedrine, pseudoephedrine,
and phenylpropanolamine but do not
include imports of controlled
substances for use in industrial
processes.
On July 2, 2014, a notice titled,
‘‘Proposed Aggregate Production Quotas
for Schedule I and II Controlled
Substances and Proposed Assessment of
Annual Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2015’’ was
published in the Federal Register. 79 FR
37772. This notice proposed the 2015
aggregate production quotas for each
basic class of controlled substance listed
in schedules I and II and the 2015
assessment of annual needs for the list
I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine. All interested
persons were invited to comment on or
object to the proposed aggregate
production quotas and the proposed
assessment of annual needs on or before
August 1, 2014.
Comments Received
Five comments were received from
DEA-registered manufacturers within
the published comment period, offering
comments on a total of 32 schedule I
and II controlled substances. None of
the respondents commented on the list
I chemicals ephedrine,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
pseudoephedrine, and
phenylpropanolamine. Commenters
stated that the proposed aggregate
production quotas for 1-(1,3Benzodioxol-5-yl)-2-(methylamino)
butan-1-one (butylone), 1-(1,3Benzodioxol-5-yl)-2-(methylamino)
pentan-1-one (pentylone), 2-(4-Bromo2,5-dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25BNBOMe), 2-(4-Chloro-2,5dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25CNBOMe), 2-(4-Iodo-2,5dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine (25INBOMe), 2-(Methylamino)-1phenylpentan-1-one (pentedrone), 3Fluoro-N-methylcathinone (3-FMC), 4Fluoro-N-methylcathinone (4-FMC), 4Anilino-N-phenethyl-4-piperidine
(ANPP), 4-Methyl-N-ethylcathinone (4MEC), 4-Methyl-apyrrolidinopropiophenone (4-MePPP),
alpha-Pyrrolidinobutiophenone (aPBP), alpha-Pyrrolidinopentiophenone
(a-PVP), amphetamine (for sale),
codeine (for sale), dihydrocodeine,
diphenoxylate, fentanyl, hydrocodone
(for sale), hydromorphone, levorphanol,
marihuana, morphine (for conversion),
N-(1-Amino-3,3-dimethyl-1-oxobutan-2yl)-1-pentyl-1H-indazole-3-carboxamide
(ADB-PINACA), N-(1-Amino-3-methyl1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1Hindazole-3-carboxamide (ABFUBINACA), naphthylpyrovalerone
(naphyrone), oripavine, oxycodone (for
conversion), oxymorphone (for
conversion), oxymorphone (for sale),
Quinolin-8-yl 1-(5-fluoropentyl)-1Hindole-3-carboxylate (5-Flouro-PB-22),
and Quinolin-8-yl 1-pentyl-1H-indole-3carboxylate (PB-22) were insufficient to
provide for the estimated medical,
scientific, research, and industrial needs
of the United States, export
requirements, and the establishment
and maintenance of reserve stocks.
Determination of 2015 Aggregate
Production Quotas and Assessment of
Annual Needs
In determining the 2015 aggregate
production quotas and assessment of
annual needs, the DEA has taken into
consideration the above comments
along with the factors set forth at 21
CFR 1303.11 and 21 CFR 1315.11, in
accordance with 21 U.S.C. 826 (a), and
other relevant factors, including the
consideration of 2014 manufacturing
quotas, current 2014 sales and
inventories, 2015 export requirements,
industrial use, additional applications
for quotas, as well as information on
research and product development
requirements. Based on this
information, the DEA has determined
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 79, Number 173 (Monday, September 8, 2014)]
[Notices]
[Pages 53215-53216]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21286]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993; Cooperative Research Group on Separation
Technology Research Program
Notice is hereby given that, on August 8, 2014, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Southwest Research Institute--
Cooperative Research Group on Separation Technology Research Program
(``STAR'') has filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing (1) the
identities of the parties to the venture and (2) the nature and
objectives of the venture. The notifications were filed for the purpose
of invoking the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the identities of the parties
to the venture are: Aker Process Systems, Fornebu, Norway; Amistco
Separation Products, Inc, dba AMACS Process Tower Internals, Houston,
TX; Chevron Energy Technology Co., a Division of Chevron USA, Inc.,
Houston, TX; ExxonMobil Upstream Research Co., Houston, TX; FMC
Separation Systems B.V., Arnhem, The Netherlands; Frames Separation
Technologies B.V., Utrecht, The Netherlands; KGGP, LLC, Wichita, KS;
Linde Engineering North America Inc., Blue Bell, PA; PetroSkills, LLC,
Katy, TX; Rhodius GmbH, Bayern, Germany; Shell International
Exploration and Production Inc., Houston, TX; Total E&P Recherche Et
Developpement, Paris, France; Wartsila Oil & Gas Systems AS, Asker,
Norway; Sulzer Chemtech Ltd., Winterthur, Switzerland; and OneSubsea
LLC, Houston, TX. The general area of STAR's planned activity is to
increase fundamental knowledge of separation technology for use in the
oil and gas industry. This will be accomplished by conducting research
related to separation technology as well as through conducting
systematic testing on and enabling qualification of separation
equipment. STAR will also develop standardized procedures for testing
equipment and conduct fundamental research on separation technology for
use by the separation
[[Page 53216]]
equipment manufacturers, separation system designers, and end users.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2014-21286 Filed 9-5-14; 8:45 am]
BILLING CODE P-
